ELDRED KARY

Average Profitability
5.2%
Insider Buys Quantity
9
Insider Buys Sum
$35,174.07
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of ELDRED KARY

According to the SEC Form 4 filings, ELDRED KARY, being in a position of

  1. director at Galectin Therapeutics Inc.,
    оver the last 12 months, has bought 1800 shares for $4,105, and sold 0 shares,
    over all time since 2018-09-25, has bought 10731 share for $35,174, and sold 0 shares.

The largest purchase of all time was on 2019-05-31 and amounted to 3033 shares of Galectin Therapeutics Inc. for $12,981.

Biography of ELDRED KARY

No biography is available at this moment.

2024-10-23PurchaseGalectin Therapeutics Inc.
GALT
director
500
0.0008%
$2.60$1,3000%
2024-07-22PurchaseGalectin Therapeutics Inc.
GALT
director
400
0.0006%
$2.39$956+6.05%
2024-01-16PurchaseGalectin Therapeutics Inc.
GALT
director
500
0.0008%
$1.79$893+41.21%
2024-01-16PurchaseGalectin Therapeutics Inc.
GALT
director
400
0.0008%
$2.39$956+41.21%
2023-07-19PurchaseGalectin Therapeutics Inc.
GALT
director
1,598
0.0028%
$1.79$2,854+14.62%
2023-02-21PurchaseGalectin Therapeutics Inc.
GALT
1,000
0.0017%
$1.59$1,591+10%
2023-01-25PurchaseGalectin Therapeutics Inc.
GALT
director
1,300
0.0022%
$1.11$1,443+60%
2019-05-31PurchaseGalectin Therapeutics Inc.
GALT
director
3,033
0.0064%
$4.28$12,981-23.33%
2018-09-25PurchaseGalectin Therapeutics Inc.
GALT
director
2,000
0.0049%
$6.10$12,200-25.86%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.